<DOC>
	<DOCNO>NCT00752414</DOCNO>
	<brief_summary>Patients Chronic Obstructive Pulmonary Disease ( COPD ) suffer frequent recurrent acute exacerbation ( AECB ) associate enormous healthcare expenditures significant morbidity , specifically increase risk death , decline pulmonary function significant change quality life . Bacteria appear important role acute exacerbation chronic bronchitis COPD . Studies acute exacerbation COPD show reduction bacterial load prolong exacerbation-free interval . In addition , recent study indicate acquisition new strain H. influenzae , M. catarrhalis , S. pneumoniae P. aeruginosa responsible many exacerbation . Chronic inflammation bacterial infection predispose many patient frequent recurrent acute exacerbation . Mpex believe intermittent administration inhale MP-376 high risk patient decrease incidence acute exacerbation lower organism burden , resultant inflammation , well pre-emptive eradication newly acquire bacterial strain .</brief_summary>
	<brief_title>A Phase 1b Study Evaluate Safety PK MP-376 Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description>This study Phase 1b , multi-center , randomize , single-blind , placebo-controlled study evaluate safety , tolerability , pharmacokinetics MP-376 solution inhalation give 5 day COPD patient .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>Inclusion Criteria ( select ) : &gt; /= 40 year age History COPD FEV1 &lt; /= 65 % predict FEV1/FVC &lt; /= 0.7 value Screening Clinically stable change health status within last 30 day Lifetime smoke history least 15 packyears Willing able give inform consent Exclusion Criteria ( select ) : Use systemic inhaled antibiotic within 30 day prior baseline History hypersensitivity fluoroquinolones intolerance aerosol medication CrCl &lt; 50/ml/min , AST , ALT total bilirubin &gt; /= 3 x ULN Screening Significant unstable medical condition</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>COPD</keyword>
	<keyword>Patients</keyword>
</DOC>